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Urea induces macrophage proliferation by inhibition of
inducible nitric oxide synthesis1
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Urea induces macrophage proliferation by inhibition of induc- levels of triglycerides, low-density lipoproteins, or lipo-
ible nitric oxide synthesis. protein(a) [3]. The dose-dependent inhibition of induc-
Background. Atherosclerosis is a major cause of morbidity ible nitric oxide synthesis for lipopolysaccharide (LPS)-and mortality in chronic renal failure and is associated with
activated macrophages incubated with urea in vitro hasthe proliferation of macrophages within atherosclerotic lesions.
been recently described [4].Methods. Because the progression of atherosclerosis as a
consequence of decreased nitric oxide synthesis has been de- The development of atherosclerotic lesions as a conse-
scribed, we investigated the correlation between the inhibition quence of decreased nitric oxide (NO) synthesis has been
of inducible nitric oxide synthase (iNOS) by urea, macrophage reported [5, 6]. Anti-atherogenic properties of NO in-proliferation as assayed by cell counting, tritiated thymidine
clude antiproliferative actions, such as the inhibition ofincorporation and measurement of cell protein, and macro-
smooth muscle cell and T-cell proliferation [7], reducedphage apoptosis.
Results. Urea induces a dose-dependent inhibition of induc- neutrophil adhesion [8, 9], inhibition of platelet activa-
ible nitric oxide synthesis in lipopolysaccharide-stimulated tion [10], and the reduction of endothelial hyperpermea-
mouse macrophages (RAW 264.7) with concomitant macro- bility [11]. The low release of NO, both basal and stimu-phage proliferation. Macrophage proliferation, as determined
lated, has been reported for atherosclerotic vessels [12].by cell counting, became statistically significant at 60 mm urea,
Atherosclerosis-associated factors with the ability to re-corresponding to a blood urea nitrogen level of 180 mg/100
ml, concentrations seen in uremic patients. iNOS protein ex- duce NO synthesis include oxidatively modified low-den-
pression showed a dose-dependent reduction, as revealed by sity lipoproteins [13] and heat-shock proteins [14].
immunoblotting when cells were incubated with increasing Nitric oxide is synthesized from l-arginine by theamounts of urea. The decrease of cytosolic DNA fragments in
l-arginine NO pathway [15] and is converted to nitritestimulated macrophages incubated with urea shows that the
proliferative actions of urea are associated with a decrease of and nitrate in oxygenated solutions [16]. A family of
NO-induced apoptosis. enzymes, termed the NO synthases (NOS), catalyze the
Conclusions. Our data demonstrate that the inhibition of formation of NO and citrulline from l-arginine, O2, andiNOS-dependent NO production caused by urea enhances mac-
nicotinamide adenine dinucleotide phosphate (NADPH)rophage proliferation as a consequence of diminished NO-
[17]. The constitutive NOS isoforms (NOS-1 and NOS-3)mediated apoptosis.
produce low levels of NO as a consequence of increased
intracellular Ca21 [18]. By contrast, the inducible isoform
of NOS (NOS-2 or iNOS) generates large amounts ofAtherosclerosis is a major cause of morbidity and mor-
NO over a prolonged period of time through a Ca21-tality in chronic renal failure (CRF) [1, 2]. Vascular dis-
independent pathway [19]. iNOS expression has beenease in uremic patients cannot be entirely explained by
observed in many cells, including murine macrophagesthe prevalence of established risk factors for atheroscle-
[20], endothelial cells [21], smooth muscle cells [22], androsis such as hypertension or an increase in the serum
cardiac myocytes [23]. NO inhibits the proliferation of
vascular smooth muscle cells, mesangial cells, and fibro-
1 See Editorial by Himmelfarb, p. 754. blasts [7, 24, 25]. High levels of NO induce changes sug-
gestive of apoptosis in mouse peritoneal macrophages andKey words: cell culture, atherosclerosis, apoptosis, inducible nitric oxide
synthase, nitric oxide. in the RAW 264.7 mouse macrophage cell line [26–28].
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macrophage proliferation. Using LPS-stimulated macro- Tritiated thymidine incorporation
phages, we examined the influence of iNOS antagonists Macrophage growth was assayed by the incorporation
(l-NAME), NO donors (NOC 18), and NO scavengers of [3H]thymidine (20 Ci/mmol) into cellular DNA.
[2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline- [3H]thymidine (1 mCi/well) was added directly to the
1-oxyl-3-oxide (carboxy-PTIO), hemoglobin] on urea- culture medium for the last two hours of incubation. The
induced macrophage proliferation. The inhibition of in- medium was aspirated, and the cells were washed with
ducible NO synthesis by urea might initiate macrophage 500 ml phosphate-buffered saline on ice before the addi-
proliferation because NO decreases cell proliferation by tion of 500 ml methanol. Cell DNA was precipitated by
increasing the rate of apoptosis. This might be a key event adding 500 ml of 10% trichloroacetic acid. Precipitates
for the development of atherosclerotic lesions in uremia. were lyzed with 200 ml of 300 mm sodium hydroxide
containing 1% sodium dodecyl sulfate. Samples were
aspirated and subjected to liquid scintillation counting.
METHODS
Cell number determinationMaterials
To determine the number of RAW 264.7 cells during[3H]Thymidine (20 Ci/mmol) was obtained from ICN
culture, the number of adherent cells was counted withinPharmaceuticals (Costa Mesa, CA, USA). 2,29-(Hydroxy-
standard-sized areas (0.25 mm2) in each of three wellsnitrosohydrazino) bis-etanamine (NOC 18) and carboxy-
by inverted, phase-contrast microscopy.PTIO were obtained from Dojindo Laboratories (Tokyo,
Japan). Rabbit anti-iNOS polyclonal antibody and puri-
Cell protein
fied iNOS protein were supplied by Calbiochem (San
Protein was determined according to the method ofDiego, CA, USA). Cell culture materials, Escherichia
Bradford using bovine serum albumin as standard [33].coli lipopolysaccharide serotype 055:B5 (LPS), and all
other chemicals were obtained from Sigma Chemical Co. DNA fragmentation assay
(St. Louis, MO, USA).
Cytosolic DNA fragments were quantitated by a cell
death detection enzyme-linked immunosorbent assayCell culture
(Boehringer Mannheim, Mannheim, Germany). TheThe mouse monocyte/macrophage cell line RAW
assay is based on the sandwich-enzyme-immunoassay264.7 (ATCC TIB 67) was cultured in Dulbecco’s modi-
principle using mouse monoclonal antibodies directed
fied Eagle’s medium (DMEM) supplemented with 10%
against histone-associated DNA fragments. Cells were
fetal bovine serum (FBS), 25 mm HEPES, 2 mm gluta-
washed with phosphate-buffered saline and lyzed with
mine, 100 U penicillin/ml, and 100 mg streptomycin/ml enzyme-linked immunosorbent assay buffer. The lysates
at 378C, 5% CO2, and 95% humidity. Cells were studied were centrifuged at 200 g for 10 minutes. The histone-
between passages 7 to 20. Cells were seeded in 24-well associated DNA fragments of the supernatant were
dishes at a density of 2 3 105 cells per well, stimulated linked to the biotinylated antihistone antibody bound to
by LPS (1 mg/ml), and incubated either with or without the streptavidin-coated microtiter plate, as described by
the indicated amount of urea for 48 hours. the manufacturer. The DNA part of the nucleosomes
was detected by peroxidase-labeled anti-DNA antibody.Nitrite analysis
The amount of histone-associated DNA fragments was
Nitrite was determined spectrophotometrically by us- quantitated spectrophotometrically with 2.29-azino-di(3-
ing the Griess reagent (0.5% sulfanilic acid, 0.002% N-1- ethylbenzthiazolin-sulfonate) as the substrate. Samples
naphtyl-ethylenediamine dihydrochloride, 14% glacial were read at 405 nm and 492 nm on a Perkin-Elmer
acetic acid) in supernatants. Absorbance was measured Lambda 2 Spectrophotometer.
at 550 nm, with baseline correction at 650 nm, and the
nitrite concentration was determined using sodium ni- Western blotting for inducible nitric oxide synthase
trite as a standard [31]. Cells were lyzed in ice-cold buffer containing 25 mm
monosodium phosphate (pH 7.4), 75 mm NaCl, 5 mm
Oxyhemoglobin preparation ethylenediaminetetraacetic acid (EDTA), 1% Triton
Oxyhemoglobin was prepared from methemoglobin X-100, 100 mg/ml phenylmethylsulfonylfluoride, 10 mg/
by reduction with excess sodium dithionite. Oxyhemo- ml antipain, 10 mg/ml leupeptin, 10 mg/ml pepstatin, 20
globin was desalted and purified by passage through a mg/ml aprotinin, and 10 mg/ml trypsin inhibitor and were
Econopac 10-DG column (Bio-Rad Laboratories, Rich- centrifuged at 50,000 g for 20 minutes at 48C. The cyto-
mond, CA, USA) and was identified spectrophotometri- solic proteins (20 mg per lane) were separated by 8%
sodium dodecyl sulfate-polyacrylamide gel electrophore-cally [32].
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Measurements of cytotoxicity were performed to exclude
toxic effects of urea toward RAW 264.7 cells. Up to a
concentration of 150 mm urea, cell viabilities were more
than 95%, as measured by trypan blue exclusion. To
exclude an interference of urea with the detection of
nitrite by the Griess reaction, we incubated the NO donor
NOC 18 (30 mg/ml) with increasing amounts urea. Urea
(0 to 150 mm) failed to affect nitrite measured from the
NO donor NOC 18 for up to 48 hours (data not shown).
Effects of urea on inducible nitric oxide synthase
protein expression
Figure 2 shows the Western blot analysis of iNOS
in RAW 264.7 cells. LPS-stimulated macrophages were
cultured with increasing amounts of urea (0 to 120 mm)
for 48 hours. Immunoblotting shows a band with an
estimated molecular mass of 130 kDa (the known molec-
ular mass of iNOS) in stimulated RAW 264.7 mouseFig. 1. Dose-dependent inhibition of inducible nitric oxide (NO) pro-
macrophages. An identical molecular mass was deter-duction by urea in RAW 264.7 cells. Cells were activated with 1 mg/ml
lipopolysaccharide (LPS) and incubated with increasing amounts of mined by blotting against purified iNOS protein. iNOS
urea as indicated. NO production was determined as nitrite accumula- protein showed a dose-dependent reduction when cellstion in the medium after 48 hours, as described in the Methods section.
were incubated with 0 to 120 mm urea. In contrast, actinEach bar shows the mean of triplicate measurements. Error bars show
the sd. *P , 0.05 when compared with controls without urea. (43 kDa) levels remained unchanged during incubations
of LPS-stimulated RAW 264.7 mouse macrophages with
increasing amounts of urea. This shows that high concen-
trations of urea do not cause a generalized decrease in
sis. Proteins were transferred to nitrocellulose filters and protein expression.
then immunoblotted with a rabbit anti-iNOS polyclonal
antibody at a 1:1000 dilution. Antirabbit horseradish per- Effects of urea on macrophage growth
oxidase-conjugated antibody was used as a secondary Tritiated thymidine incorporation was determined in
antibody at a dilution of 1:2500. The blots were detected LPS-stimulated and -unstimulated cells to examine
with the enhanced chemiluminescence method and were whether inhibition of inducible NO synthesis by urea
exposed to photographic film. stimulates the proliferation of RAW 264.7 macrophages.
iNOS induction by LPS reduced basal tritiated thymidineData analysis
incorporation of RAW 264.7 cells by more than 90%.
Each experimental result, as shown in the figures, is The inhibition of basal tritiated thymidine incorporation
the mean 6 sd for at least three measurements. When was antagonized by urea. As shown in Figure 3, the
the sd is not displayed, it is smaller than the size of the tritiated thymidine uptake increased 9.8-fold after a 48-
symbol. Statistical analyses were performed using analysis hour incubation with 90 mm urea for stimulated cells in
of variance, followed by Student’s t-tests for unpaired contrast to a slight decrease for unstimulated cells when
data. Statistical significance was defined as P , 0.05. compared with controls without urea. Tritiated thymi-
dine incorporation increased in a dose-dependent man-
ner up to 120 mm urea for LPS-stimulated macrophages.RESULTS
Higher urea concentrations decreased the incorporation
Inhibition of inducible nitric oxide synthesis by urea of tritiated thymidine into cellular DNA (data not shown).
Monolayers of RAW 264.7 macrophages were acti- These results suggest that urea has the capability to aug-
vated with 1 mg/ml LPS and incubated with increasing ment growth (that is, increase in cell number) of LPS-
amounts (0 to 120 mm) of urea as indicated. After 48 stimulated RAW 264.7 macrophages.
hours, the culture media were collected and assayed for In addition, the number of macrophages per well was
nitrite, as described in the Methods section. Activated determined by inverted phase-contrast microscopy for
RAW 264.7 cells released large amounts of nitrite into LPS-stimulated cells to prove that urea stimulates the
the culture medium (69 6 7.3 nmol nitrite per mg protein proliferation of RAW 264.7 macrophages (Fig. 4). Cells
within 48 hr). Incubation of activated RAW 264.7 cells were seeded at a density of 2 3 105 per well in 24-well
with increasing amounts of urea was associated with a plates. Stimulation by LPS reduced the proliferation of
RAW 264.7 cells within 48 hours from 183 6 17% (in-dose-dependent reduction in NO production (Fig. 1).
Moeslinger et al: Urea and cell proliferation by iNOS inhibition584
Fig. 2. Immunoblotting against inducible ni-
tric oxide synthase (iNOS). Lipopolysaccharide
(LPS)-stimulated RAW 264.7 mouse macro-
phages were cultured with increasing amounts
of urea (0 to 120 mm) for 48 hours. Western
blotting was performed as described in the
Methods section. Lane 1, control incubations
(stimulated RAW 264.7 mouse macrophages
without urea); lanes 2 through 4, incubations
containing 30 to 120 mm urea. Immunoblotting
identified a band with an estimated molecular
mass of 130 kDa in stimulated RAW 264.7
mouse macrophages. iNOS was markedly re-
duced in cells incubated with urea (lanes 2
through 4). In contrast, actin (43 kDa) levels
remained unchanged during incubations of
LPS-stimulated RAW 264.7 mouse macro-
phages with increasing amounts of urea.
Fig. 4. Urea-induced macrophage proliferation. RAW 264.7 macro-
phages were stimulated with lipopolysaccharide (LPS) and were incu-
Fig. 3. Effects of urea on macrophage proliferation measured as triti- bated with increasing amounts (0 to 150 mm f.c.) of urea for 48 hours.
ated thymidine incorporation. Monolayers of RAW 264.7 monocyte/ Cell counting was performed by phase-contrast microscopy as described
macrophages were activated with 1 mg/ml LPS (s) or not activated (d) in the Methods section and is shown as cell number 3 105 per well.
and incubated with increasing amounts (0 to 120 mm f.c.) of urea as Data show the mean of triplicate measurements 6 sd and are represen-
indicated for 48 hours. [3H]Thymidine was added directly to the incuba- tative of three independent experiments. *P , 0.05 compared with
tion medium, and thymidine incorporation into DNA was analyzed as control incubations without urea.
described in the Methods section. Data show the mean of triplicate
measurements 6 sd and are representative of three independent experi-
ments.
cells/well for control incubations without urea to 3.18 6
0.22 3 105 cells/well for 90 mm urea and 3.36 6 0.38 3crease in cell number) for unstimulated macrophages to
105 cells/well for 150 mm urea (P , 0.05). The addition4.7 6 6.1% for stimulated cells. Macrophage proliferation
of urea to unstimulated cells resulted in a decrease ofwas enhanced because of the addition of urea to stimu-
lated cells. Cell number increased from 2.09 6 0.12 3 105 cell number from 5.68 6 0.35 3 105 cells/well for control
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Fig. 6. Inhibition of inducible nitric oxide synthesis by urea prevents
Fig. 5. Effects of nitric oxide (NO) donors and urea on macrophage apoptosis in RAW 264.7 macrophages. Apoptosis was quantitated by
growth in vitro as quantitated by cell counting. Lipopolysaccharide detection of histone-associated DNA fragments, as described in the
(LPS)-stimulated RAW 264.7 mouse macrophages were seeded at a Methods section. Stimulated RAW 264.7 mouse macrophages were
density of 2 3 105 per well and were cultured with or without 120 mm cultured with or without 120 mm urea for 12 hours. Urea inhibits apopto-
urea for 24 hours. Urea-induced proliferation was inhibited by the NO sis of macrophages expressing inducible nitric oxide synthase (iNOS)
donor NOC 18 (30 mg/ml, P , 0.005). The inhibition of cell proliferation activity (P , 0.02). Decreased DNA fragmentation by urea was in-
by NOC 18 could be antagonized by adding NO scavengers carboxy- creased by the NO donor NOC 18 (30 mg/ml, P , 0.005). The NO-
PTIO (10 mg/ml, P , 0.02) and oxygenated hemoglobin (100 mm HbO2, mediated increase in apoptosis could be antagonized by adding the
P , 0.005). Values are given as cell number 3 105 per well. Error bars NO scavengers carboxy-PTIO (10 mg/ml, P , 0.01) and oxygenated
represent sd of triplicate measurements. hemoglobin (100 mm HbO2, P , 0.01). Error bars represent sd.
incubations without urea to 4.44 6 0.86 3 105 cells/well
for 90 mm urea and 4.16 6 0.79 3 105 cells/well for 150 eration of LPS-stimulated macrophages by 120 mm urea
mm urea (differences not statistically significant). The in vitro, as quantitated by cell counting after a 48-hour
estimation of cell proliferation by measuring cell protein, incubation. Urea-induced proliferation was inhibited by
as described in the Methods section, gave comparable the NO donor NOC 18 (30 mg/ml, P , 0.005). This inhibi-
results. A correlation between the means of thymidine tion of cell proliferation could be antagonized by adding
incorporation and cell count was linear with a correlation the NO scavengers carboxy-PTIO (10 mg/ml, P , 0.02)
coefficient of 0.94. The correlation between the means and oxygenated hemoglobin (100 mm HbO2, P , 0.005).of cell protein and cell count was linear with r 5 0.99.
The addition of the NOS inhibitor l-NAME (300 mm Effects of urea and nitric oxide on
final concentration) to LPS-stimulated RAW 264.7 macro-
macrophage apoptosisphages increased the cell number after a 48-hour incuba-
Nitric oxide-induced apoptosis has been described fortion from 2.09 6 0.12 3 105 (control incubations without
various cell lines [26, 34, 35]. To test if urea-inducedl-NAME) to 2.94 6 0.25 3 105 cells/well. This was ac-
companied by an almost complete inhibition of NO syn- inhibition of inducible NO synthesis prevents apoptosis
thesis. The addition of urea (0 to 150 mm) to l-NAME in RAW 264.7 macrophages, we assessed cytosolic DNA
containing incubations showed no further statistically fragments as described in the Methods section. Urea
significant increase in cell number (data not shown). (120 mm) inhibits the apoptosis of macrophages express-
This hints to the fact that urea-induced proliferation ing iNOS activity (P , 0.02; Fig. 6). The reduced DNA
of stimulated macrophages is a consequence of iNOS fragmentation by urea was increased by the NO donor
inhibition. NOC 18 (30 mg/ml, P , 0.005). The NO-mediated in-
crease in apoptosis could be antagonized by adding NOEffect of nitric oxide on urea-induced
scavengers carboxy-PTIO (10 mg/ml, P , 0.01) and oxy-macrophage proliferation
genated hemoglobin (100 mm HbO2, P , 0.01). The de-We next examined whether the increased macrophage
crease of cytosolic DNA fragments in stimulated macro-proliferation could be antagonized by the addition of a
phages incubated with urea shows that the proliferativeNO donor (NOC 18) and if the antiproliferative actions
actions of urea are associated with a decrease of NO-of NO could be reversed by NO scavengers (carboxy-
PTIO, hemoglobin). Figure 5 shows the increased prolif- induced apoptosis.
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DISCUSSION iNOS activity for the development of atherosclerotic le-
sions in CRF. Urea concentrations of up to 60 mm areThis article shows a correlation between the urea-
seen in patients suffering from CRF without renal re-induced inhibition of iNOS and macrophage growth. Re-
placement therapy [4, 38]. Nowadays, such values cannotcently, the inhibition of iNOS by urea has been demon-
be considered an adequate target of urea control becausestrated [4]. When activated cells were incubated with
the widespread use of dialysis has become state-of-the-urea up to 100 mm, almost complete inhibition of induc-
art therapy for patients suffering from CRF. Thus, dial-ible NO synthesis was observed. Northern blot analysis
ysis promises to prevent the urea-associated proliferativeof iNOS mRNA showed a less than 10% difference in
effects by preventing urea-induced inhibition of iNOS.signal between LPS and LPS 1 urea incubations, whereas
Our data show that inhibition of iNOS-dependent NOdifferences of NO synthesis between these groups were
production by urea enhances macrophage proliferationmore than 400%. Our results show a distinct reduction
and is associated with diminished NO-mediated apopto-of iNOS protein in cells incubated with increasing
sis. NO has previously been shown to inhibit DNA syn-amounts of urea as revealed by immunoblotting. From
thesis, cell growth, and division [7, 39]. In addition, induc-these data it can be concluded that the inhibitory effects
tion of iNOS was shown to be associated with an increasedof urea toward inducible NO synthesis seem to act on a
apoptosis rate of murine peritoneal macrophages [26].translational level.
As a consequence, NO synthesis by iNOS correlatesThe development of atherosclerotic lesions as a con-
inversely with macrophage lifespan in vitro. It has beensequence of chronic inhibition of NO production by
proposed that the NO-dependent death of murine peri-l-NAME has been reported [5, 6]. Morphometric analy-
toneal macrophages activated in vitro with interferon-gses revealed a marked enlargement of intimal atheroscle-
and LPS is mediated through apoptosis. This was shownrotic areas in aortas from l-NAME–treated animals.
by microscopic examination of the cells, which revealedl-NAME inhibits both inducible and constitutive NOS.
the presence of nuclear and cytoplasmic alterations char-The expression of iNOS within macrophages of athero-
acteristic of apoptosis and by the specific pattern of in-
sclerotic lesions has been described [36, 37]. iNOS was
ternucleosomal DNA fragmentation detected by electro-
not detected in normal vessels, but widespread iNOS phoresis [26]. NO-induced apoptosis is presumed to be
protein staining was found in macrophages, foam cells, due to cGMP-dependent protein kinase G activation
and vascular smooth muscle cells of early and advanced [40]. Inhibition of NO formation by N-monomethyl-l-
atherosclerotic lesions. The inhibition of iNOS by urea arginine (l-NMA) diminishes apoptosis of LPS-activated
might contribute to the development of atherosclerotic RAW 264.7 macrophages [41].
plaques by an increased proliferation of macrophages According to our opinion, there is no need to reduce
because of the diminished release of antiproliferative erythropoietin administration during the treatment of
NO in these lesions. anemia found in patients suffering from CRF, although
Macrophages are commonly detected in experimental hemoglobin is known to antagonize the biological effects
and human atherosclerotic plaques. Autoradiographic of NO and reduces NO-induced apoptosis, as shown in
and ultrastructural observations in human fibro-athero- Figure 6. Erythropoietin administration raises hemato-
matous plaques showed that most of the autoradio- crit levels and increases hemoglobin, which is found pre-
graphic staining appeared on foam cells and monocyte- dominantly within the erythrocyte and only to a minor
like cells, thus suggesting a local proliferation of these extent in its free form in the plasma. On the other hand,
cells [29]. Simultaneous thymidine autoradiography and macrophage proliferation representing a hallmark for
immunostaining with cell-type–specific monoclonal anti- the development of atherosclerotic lesions takes place
bodies revealed that approximately 30% of the labeled within the vessel wall, where the cellular populations can
cells were macrophages and 45% were smooth muscle be considered to be “out of reach” for almost any free
cells in advanced atherosclerotic lesions [30]. Increased hemoglobin.
macrophage proliferation resulting from a urea-induced The appearance of macrophages within atheroscle-
iNOS inhibition might enhance the development of ath- rotic lesions has been supposed to be the consequence
erosclerotic lesions. of an increased recruitment of monocytes via a nuclear
As shown in Figure 4, macrophage proliferation (in- factor-kB (NF-kB)-dependent expression of vascular en-
crease in cell number) as a consequence of urea-induced dothelial cell adhesion-molecule 1 (VCAM-1), macro-
inhibition of inducible NO synthesis became statistically phage colony-stimulating factor (M-CSF), and monocyte
significant at concentrations of 60 mm urea, correspond- chemoattractant protein-1 (MCP-1) by human vascular
ing to a blood urea nitrogen concentration of approxi- endothelial cells. NO has been shown to inhibit VCAM-1
mately 180 mg/100 ml. These concentrations are seen in [8], M-CSF [42], and MCP-1 expression [9] by inhibiting
uremic patients, implicating a pathophysiological relevance NF-kB activation. The inhibition of NO synthesis by
l-NMA was shown to activate NF-kB with concomitantof urea-induced proliferation of macrophages expressing
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modulates the expression of monocyte chemoattractant protein 1VCAM-1, M-CSF, and MCP-1 expression [8, 9, 42]. Inhi-
in cultured human endothelial cells. Circ Res 76:980–986, 1995
bition of inducible NO synthesis by urea might influence 10. Schafer AI, Alexander RW, Handin RI: Inhibition of platelet
function by organic nitrate vasodilators. Blood 55:649–654, 1980macrophage accumulation within atherosclerotic lesions
11. Suttorp N, Hippenstiel S, Fuhrmann M, Krull M, Podzuweitin addition to a decreased apoptosis rate by enhancing
T: Role of nitric oxide and phosphodiesterase isoenzyme II for
NF-kB–dependent VCAM-1, M-CSF, and MCP-1 ex- reduction of endothelial hyperpermeability. Am J Physiol 270:
C778–C785, 1996pression. Although our data suggest a causative role of
12. Chester AH, O’Neil GS, Moncada S, Tadjkarimi S, Yacoub MH:urea-induced inhibition of inducible NO synthesis with
Low basal and stimulated release of nitric oxide in atherosclerotic
respect to an increased cellular proliferation as a hall- epicardial coronary arteries. Lancet 336:897–900, 1990
13. Yang X, Cai B, Sciacca RR, Cannon PJ: Inhibition of induciblemark of the development of atherosclerotic lesions, in
nitric oxide synthase in macrophages by oxidized low-density lipo-vivo proof that the effects of urea on iNOS are responsi-
proteins. Circ Res 74:318–328, 1994
ble for changes in cellular proliferation is still lacking. 14. Wong HR, Finder JD, Wasserloos K, Pitt BR: Expression of
iNOS in cultured rat pulmonary artery smooth muscle cells isNumerous anti-atherogenic properties of NO in vitro
inhibited by the heat shock response. Am J Physiol 269:L843–L848,have been described. NO inhibits smooth muscle cell pro-
1995
liferation [7], platelet activation [10], neutrophil adhesion 15. Palmer RM, Ashton DS, Moncada S: Vascular endothelial cells
synthesize nitric oxide from L-arginine. Nature 333:664–666, 1988[43], and MCP-1 expression [9] and inhibits NF-kB acti-
16. Marletta MA, Yoon PS, Iyengar R, Leaf CD, Wishnok JS:vation [9, 42]. Our results support the hypothesis that
Macrophage oxidation of L-arginine to nitrite and nitrate: Nitric
inducible NO release protects against atherogenesis by oxide is an intermediate. Biochemistry 27:8706–8711, 1988
17. Marletta MA: Nitric oxide synthase structure and mechanism.preventing macrophage proliferation. Urea might con-
J Biol Chem 268:12231–12234, 1993tribute to the development of atherosclerotic lesions as-
18. Nathan C, Xie QW: Nitric oxide synthases: Roles, tolls, and con-
sociated with CRF and elevated blood urea nitrogen trols. Cell 78:915–918, 1994
19. Xie QW, Cho HJ, Calaycay J, Mumford RA, Swiderek KM, Leelevels by reducing inducible NO synthesis with concomi-
TD, Ding A, Troso T, Nathan C: Cloning and characterization oftant macrophage proliferation as a consequence of di-
inducible nitric oxide synthase from mouse macrophages. Science
minished macrophage apoptosis. 256:225–228, 1992
20. Hibbs JB Jr, Taintor RR, Vavrin Z, Rachlin EM: Nitric oxide:
A cytotoxic activated macrophage effector molecule. Biochem Bio-ACKNOWLEDGMENTS
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